Manufacturing

Articles

This article investigates the chiral method development screening for the enantiomeric separation of synthetic CBD on polysaccharide-based chiral stationary phases with both normal-phase and reversed phase mobile phases, using HPLC and UHPLC

The Chiral Separation of the (+) and (-) Enantiomers of Cannabidiol

In this article, regulatory requirements are explored as they are meant to create confidence that cannabis and cannabis-infused products are safe to use.

Improving Quality in Cannabis Testing Laboratories: Making ISO/IEC 17025 Work for Your Laboratory and Customers

David Hodes has written for many cannabis publications, and organized or moderated sessions at national and international cannabis trade shows. He was voted the 2018 Journalist of the Year by Americans for Safe Access, the world’s largest medical cannabis advocacy organization.

The new processed cannabis products continue to attract consumers—but black market influence causes hesitancy.


More Innovative Cannabis Products Emerge Amidst Ongoing Processor Issues

This study focuses on a step-by-step optimization of commercial scale preparative HPLC purification of cannabinoids, specifically cannabidiol, starting with stationary reversed-phase screening, followed by method optimization.

Development, Optimization, and Process Performance for Preparative Chromatographic Purification of Cannabinoids

Do you know how much waste the cannabis industry produces yearly in the United States? Consumers might be aware that some cannabis packaging is recyclable, but how many are aware of the need for large-scale recycling programs to reduce the amount of packaging heading to harmful landfills? In this interview, O’Neil Rudolph, founder of cannachange, discusses how their new program connects consumers and dispensaries with accessible, sustainable recycling in the cannabis industry through an easy-to-use app.

Keeping the Cannabis Industry Green: A New Initiative Promotes Recycling and Environmental Awareness Among Consumers and Dispensaries

 is a Princeton, New Jersey-based psychiatrist, writer, speaker, educator, and consultant. He is the founder and board president of Doctors for Cannabis Regulation. Dr. Nathan is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School. He serves on the editorial board of 

Working with Doctors for Cannabis Regulation and other stakeholders, David L. Nathan, MD, proposed the Universal Cannabis Product Symbol (UCPS) in 2019. After its publication in 2020, a broad discussion with various stakeholders led to a series of changes to the UCPS. Working with the standards organization ASTM, the authors of this paper co-designed a modified version of the UCPS, which was renamed the International Intoxicating Cannabis Product Symbol (IICPS). This article presents the IICPS and next steps for the industry to start implementing its use.

Why All Legalized U.S. Jurisdictions Should (and Probably Will) Adopt the International Intoxicating Cannabis Product Symbol (IICPS)

Unrivaled Brands recently announced the launch of their new state of the art cultivation facility operating in Oakland, California.

Unrivaled Brands Launches New Cultivation Facility

A closer look at the fundamental studies of tablet formation that are critical processes to ensure successful manufacturing of THC and CBD tablet dosage forms.

Cannabis and Hemp  Tableting Challenges

This article proposes alternative and effective cleaning solutions for cannabis and hemp processing equipment.

An Essential Element  for Commercial Cannabis and Hemp Manufacturing: Practical Cleaning Solutions for Extraction and Processing Equipment

Brian C. Smith, PhD, is Founder, CEO, and Chief Technical Officer of Big Sur Scientific. He is the inventor of the BSS series of patented mid-infrared based cannabis analyzers. Dr. Smith has done pioneering research and published numerous peer-reviewed papers on the application of mid-infrared spectroscopy to cannabis analysis, and sits on the editorial board of Cannabis Science and Technology. He has worked as a laboratory director for a cannabis extractor, as an analytical chemist for Waters Associates and PerkinElmer, and as an analytical instrument salesperson. He has more than 30 years of experience in chemical analysis and has written three books on the subject. Dr. Smith earned his PhD on physical chemistry from Dartmouth College. Direct correspondence to: 

How can cannabis businesses start formulating like the pharmaceutical industry and why it’s important to do so.